Table 1.

Patient characteristics at baseline. Medians, except for HAQ score, are interquartile range (25th–75th percentile).

CharacteristicPatients (n = 20)
Age, median, yrs55 (47–63)
Men4
Women16
Disease duration at inclusion, median12.5 (9–20.75)
No. previous DMARD treatments, median4 (2.75–5)
No. previous anti-TNF agents, median2 (1.75–3)
Prior rituximab treatments6
Concomitant DMARD treatments
  Methotrexate18
  Other DMARD0
  None2
Rheumatoid factor positivity (%)14 (70)
DAS28 (CRP) median5.53 (5.05–6.35)
HAQ score median1.25 (0.875–1.375)
  • DMARD: disease-modifying antirheumatic drugs; DAS28 (CRP): Disease Activity Score in 28 joints (C-reactive protein); HAQ: Health Assessment Questionnaire; TNF: tumor necrosis factor.